Filing Details

Accession Number:
0000711377-10-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-04 06:46:30
Reporting Period:
2010-09-29
Filing Date:
2010-10-04
Accepted Time:
2010-10-04 06:46:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-29 1,823 $9.02 111,343 No 4 M Direct
Common Stock Disposition 2010-09-29 1,823 $34.39 109,520 No 4 S Direct
Common Stock Acquisiton 2010-09-29 3,917 $13.55 113,437 No 4 M Direct
Common Stock Disposition 2010-09-29 3,917 $34.39 109,520 No 4 S Direct
Common Stock Acquisiton 2010-09-30 2,467 $13.55 119,987 No 4 M Direct
Common Stock Disposition 2010-09-30 2,467 $34.00 109,520 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right to buy) Disposition 2010-09-29 1,823 $0.00 1,823 $9.02
Common Stock Common Stock Option (Right to buy) Disposition 2010-09-29 3,917 $13.55 3,917 $13.55
Common Stock Common Stock Option (Right to buy) Disposition 2010-09-30 2,467 $0.00 2,467 $13.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
103,567 2011-11-03 No 4 M Direct
9,965 2012-08-09 No 4 M Direct
97,183 2012-08-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,012 Indirect Held by Neogen 401-K Plan
Footnotes
  1. The options were granted 11/3/06 as non-qualified options and became exercisable 20% yearly thereafter.
  2. The options were granted 8/9/07 as non qualified options and became exercissable 20% yearly thereafter.